Supplementary Fig. 1 Representation of global DNA methylation of all significant CpG sites observed in patients at high risk for CVD and in healthy individuals based on A) gene regions and B) CpGisland regions. Bars (+/-SEM represent the mean global DNA methylation in each group. No statistical differences were observed (Student t-test p-value > 0.05).
Supplementary Fig. 2 UCSC tracks mapping the selected CGI upstream of the BRCA1 gene (above) and the CRISP2 gene (below). The black YourSeq track represents the location of the amplicon for MassARRAY validation. The mean DNA methylation differences between the test groups were calculated per CpG probe and mapped to UCSC by developing custom tracks (under CpG island track). The red color of the Mean Athero tracks represent DNA methylation differences higher than 10% between two groups. The blue color indicates DNA methylation differences below 5%. Further down, Roadmap Epigenomics Project tracks are shown. Active promoter regions based on histone codes are indicated in red. The last track represents one example of an active histone modification (H3K4me1) generated by Roadmap Epigenomics. Table S6 
